Search
Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More
Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More
Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article in which Sudha Seshadri, MD, founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was also mentioned. Read More
Research by The University of Texas Health Science Center at San Antonio was featured in this article. Read More
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received $3,395,970 in new academic research and prevention awards as part of the latest $98 million funding round announced on May 21 by the Cancer Research Prevention Institute of Texas (CPRIT). The state agency, which focuses on funding evidence-based cancer […]
Arash Salardini, MD, associate professor of cognitive and behavioral neurology with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was mentioned in this article. Read More
Vanessa Young, MS, clinical research project manager at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and with the Translational Science PhD program in the Graduate School of Biomedical Sciences, was quoted in this article. Read More
Archynetys.com: BRCA1 & Cancer Resistance — New Study Findings
Healthcare IT News: HIMSSCast: How an MD/MS in AI dual degree could change health IT leadership
PipelineReview.com: Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide